Bridgeway Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bridgeway Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,500	Closed	-$347K	–	1378
2019 Q4	$347K	Hold	40,500	–	–	﹤0.01%	1088
2019 Q3	$45K	Hold	40,500	–	–	﹤0.01%	1279
2019 Q2	$53K	Sell	40,500 -176,900	-81%	-$243K	﹤0.01%	1276
2019 Q1	$307K	Hold	217,400	–	–	﹤0.01%	1148
2018 Q4	$261K	Hold	217,400	–	–	﹤0.01%	1169
2018 Q3	$513K	Buy	217,400 +104,800	+93%	+$261K	0.01%	1130
2018 Q2	$307K	Buy	+112,600	New	+$311K	﹤0.01%	1246
2017 Q1	–	Sell	-119,600	Closed	-$578K	–	1489
2016 Q4	$578K	Buy	+119,600	New	+$3.55M	0.01%	1034

Other funds holding ISEE

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BCM

Burrage Capital Management Boston, Massachusetts $99.7M AUM 66.05% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bridgeway Capital Management's ISEE Position: Q1 2020 in Review

Bridgeway Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2020, closing a stake of 40,500 shares — an estimated $347K sold.

Bridgeway Capital Management first reported a position in ISEE in Q4 2016 and held it in 8 quarters. The position peaked at $578K in Q4 2016. 75 funds tracked by Wall St. Rank hold ISEE as of Q1 2020.

Bridgeway Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 40,500 IVERIC bio, Inc. Common Stock shares in Q1 2020, an estimated $347K.
Bridgeway Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
Bridgeway Capital Management's IVERIC bio, Inc. Common Stock position peaked at $578K in Q4 2016.
75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.